INTRODUCTION Powders: A powder is a homogenous mixture of more or less finely divided particulate material in dry form. Powders are one of the oldest ...
INSTITUTIONAL PERSPECTIVE ON DRUG APPROVAL PROCESS IN US, EUROPE AND JAPAN- AN OVERVIEW
INTRODUCTION Drug development is the process of bringing a new drug molecule into clinical practice.1 Drug development comprises all the activities in...
FORMULATION AND EVALUATION OF POLYHERBAL COLD CREAM
INTRODUCTION Cosmetics are the products which are generally used to beautify the skin and also to purify the skin [1]. The cosmetics are the word deri...
AN INTRODUCTION TO NEEDLE-FREE INJECTION TECHNOLOGY
INTRODUCTION Needle-free injection system or Needle-less injection technology or Needle-free injection technology was first introduced by Marshall Loc...
A SHORT REVIEW ON HEPATOTOXICITY AND HEPATOPROTECTIVE HERBS
INTRODUCTION Liver is the largest internal organ in our body performing more than 5000 separate bodily functions- from cleansing the blood of toxins t...
ACETAMINOPHEN INDUCED HEPATOTOXICITY: MECHANISM, SYMPTOMS AND TREATMENT
INTRODUCTION Acetaminophen is one of the most common medications found in households. It is used for the treatment of pain and to lower fever. Over ma...
OVERVIEW OF POLYCYSTIC OVARY SYNDROME
INTRODUCTION Polycystic ovary syndrome is complex metabolic, reproductive & endocrine disorder that effecting 5-10 % of women of age of reproducti...
DEVELOPMENT AND VALIDATION OF DISSOLUTION TEST METHOD FOR DAPAGLIFLOZIN USING RP-HPLC AND UV SPECTROPHOTOMETER
INTRODUCTION The dissolution can be defined in a narrow sense as the process by which a solid substance is incorporated into the solvent to form a sol...
Johnson & Johnson announces initiation of rolling submission for its single-dose Janssen COVID-19 vaccine candidate with the European Medicines Agency
Janssen-Cilag International N.V., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has initiated a rolling submission with the E...
Lilly announces 650,000 additional doses of neutralizing antibody bamlanivimab (LY-CoV555) purchased by U.S. government to treat COVID-19
The U.S. government has purchased 650,000 additional doses of Eli Lilly and Company’s (NYSE: LLY) neutralizing antibody bamlanivimab (LY-CoV555)...